---
schema_version: "secwatch.filing_event.v1"
accession: "0001827090-25-000018"
form_type: "8-K"
ticker: "CERT"
cik: "0001827090"
company_name: "Certara, Inc."
filed_at: "2025-03-05T23:59:59+00:00"
generated_at: "2026-05-25T11:13:57.059233+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Certara President Patrick F. Smith steps down, moves to senior advisory role

## Summary
- Dr. Patrick F. Smith stepped down as President, Certara Drug Development Solutions, effective March 3, 2025.
- Smith remains employed at Certara in a senior advisory and scientific capacity.
- No replacement for the President role was announced in the filing.

## SEC filing metadata
- accession: 0001827090-25-000018
- form_type: 8-K
- ticker: CERT
- cik: 0001827090
- company_name: Certara, Inc.
- filed_at: 2025-03-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1827090/000182709025000018/0001827090-25-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1827090/000182709025000018/certara-20250303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001827090-25-000018
- JSON: https://secwatch.observer/filing/0001827090-25-000018.json
- Plain text: https://secwatch.observer/filing/0001827090-25-000018.txt

## Key facts
- Executive change
  Dr. Patrick F. Smith departed as President, Certara Drug Development Solutions at Certara, Inc..
  - Action: stepped down
  - Role: President, Certara Drug Development Solutions
  source text: On March 5, 2025, Certara, Inc. (the “Company”) announced that Dr. Patrick F. Smith, President, Certara Drug Development Solutions, stepped down from that role as of March 3, 2025, but will remain employed by the Company in a senior advisory and scientific role.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1827090/000182709025000018/0001827090-25-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.